Qiagen price target lowered to $60 from $61.86 at Citi

Citi lowered the firm’s price target on Qiagen to $60 from $61.86 and keeps a Buy rating on the shares. The company reported Q4 results ahead of expectations in both revenue and earnings, the analyst tells investors in a research note. The firm moved estimates slightly lower post the quarter.